Target intelligence / Profile preview

Prohormone

Molecular classification
Other
01

Overview

A prohormone is a physiological precursor to a hormone, typically a protein or steroid, that possesses minimal or no biological activity until it undergoes enzymatic processing into an active form [2, 12]. In the peptide hormone system, prohormones like proinsulin and pro-opiomelanocortin (POMC) are synthesized as larger polyproteins and subsequently cleaved by specific enzymes called prohormone convertases (PCs) to generate functional signaling molecules like insulin, ACTH, and endorphins [1, 9, 10]. In a pharmacological and athletic context, the term often refers to synthetic precursors of anabolic steroids, such as androstenedione or DHEA, which are metabolized by the body into potent androgens like testosterone or dihydrotestosterone [3, 8, 14, 16]. While prohormones themselves are generally not the direct therapeutic targets of drugs, the enzymes responsible for their processing (e.g., PCSK1, PCSK9) and the receptors they eventually activate are major focuses of drug development [4, 7]. Furthermore, circulating fragments of prohormones, such as NT-proBNP and ProGRP, serve as vital diagnostic biomarkers for monitoring conditions like heart failure and small cell lung cancer [11, 15].

Other names
Hormone precursorPro-proteinPro-peptidePro-androgenPrecursor proteinHormone proform
02

Mechanism of action

Prohormones function as inactive or weakly active precursors that require enzymatic cleavage (by proteases such as prohormone convertases) or biochemical modification (by steroid-converting enzymes) to yield biologically active hormones that can bind to their respective receptors.

03

Biological functions

Signal transductionMetabolic regulationGrowth and developmentHormone synthesisHomeostasis
04

Disease associations

Metabolic syndromeObesityEndocrinopathyCancerCardiovascular diseaseDiabetes mellitus
05

Safety considerations

Hormonal dysregulation and endocrine imbalanceLiver toxicity (associated with synthetic steroid prohormones)Cardiovascular risks and cholesterol alterationsNegative feedback inhibition of endogenous hormone productionVirilization and other androgenic side effects in females and children
06

Biomarkers

N-terminal pro-B-type natriuretic peptide (NT-proBNP)Pro-gastrin-releasing peptide (ProGRP)C-peptideProinsulinPro-adrenomedullin

Beyond the preview

Go deeper on Prohormone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prohormone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call